Tacrine is a centrally acting anticholinesterase and indirect cholinergic agonist (
parasympathomimetic). It was the first centrally acting cholinesterase inhibitor ...
Jan 22, 2016 ... tacrine (Cognex - discontinued in the U.S.) is a medication prescribed for the
treatment of mild to moderate dementia associated with ...
Pictures of Cognex (Tacrine), drug imprint information, side effects for the patient.
Tacrine is an oral acetylcholinesterase inhibitor previously used for therapy of
Alzheimer disease. Tacrine therapy is associated with a very high rate of serum ...
Jun 13, 2005 ... Tacrine is postulated to exert its therapeutic effect by enhancing cholinergic
function. This is accomplished by increasing the concentration of ...
Tacrine is the first drug to be approved for the treatment of mild to moderate
The alleged success of tacrine in the treatment of these symptoms has been
heralded as confirmation of the cholinergic theory of Alzheimer's disease.
Medscape - Indication-specific dosing for Cognex (tacrine), frequency-based
adverse effects, comprehensive interactions, contraindications, pregnancy ...
Find patient medical information for tacrine oral on WebMD including its uses,
side effects and safety, interactions, pictures, warnings and user ratings.
ABSTRACT Tacrine (1,2,3,4-tetrahydro-5-aminoacridine, THA, Cognex®) has
had an interesting history since its synthesis in Australia as part of the WWII effort.